CD34: Structure, biology, and clinical utility

Blood

Volumn 87, Issue 1, 1996, Pages 1-13

  Krause, Diane S ^a   Fackler, Mary Jo ^c   Civin, Curt I ^c   May, W Stratford ^b  

^a The Leukemia & Lymphoma Society   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CD34 ANTIGEN; COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; GLYCOSYLATED PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; LEUKOSIALIN; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 115 2; MONOCLONAL ANTIBODY 12 8; MONOCLONAL ANTIBODY BI 3C5; MONOCLONAL ANTIBODY ICH3; MONOCLONAL ANTIBODY MY 10; MONOCLONAL ANTIBODY QBEND10; MONOCLONAL ANTIBODY TUK3; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE C; SIALOGLYCOPROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE GRANULOCYTIC LEUKEMIA; BONE MARROW TRANSPLANTATION; COLONY FORMING UNIT; GENE EXPRESSION; GENE THERAPY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMOGENESIS; LEUKOCYTE ADHERENCE; LYMPHOCYTE HOMING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; RNA SPLICING; TRANSCRIPTION REGULATION;

EID: 0030028585     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.1.1.bloodjournal8711     Document Type: Review

References (141)

1. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH: Antigenic analysis of hematopoiesis III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 133:157, 1984
2. Katz F, Tindle RW, Sutherland DR, Greaves MD: Identification of a membrane glycoprotein associated with hemopoietic progenitor cells. Leuk Res 9:191, 1985
3. Andrews RG, Singer JW, Bernstein ID: Monoclonal antibody 12-8 recognizes a 115-kd molecular present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 67:842, 1986
4. Fina L, Molgaard HV, Robertson D, Bradley NJ, Monaghan P, Delia D, Sutherland DR, Baker MA, Greaves MF: Expression of the CD34 gene in vascular endothelial cells. Blood 75:2417, 1990
5. Beschorner WE, Civin CI, Strauss LC: Localization of hematopoietic progenitor cells in tissue with the anti-My-10 monoclonal antibody. Am J Pathol 119:1, 1985
6. Brown J, Greaves MF, Molgaard HV: The gene encoding the stem cell antigen CD34 is conserved in mouse and expressed in haemopoietic progenitor cell lines, brain, and embryonic fibroblasts. Int Immunol 3:175, 1991
7. Civin C, Trischmann T, Fackler M, Bernstein I, Brunning J, Campos L, Greaves M, Kamoun M, Katz D, Lansdorp P, Look A, Seed B, Sutherland D, Tindle R, Uchanska-Ziegler B: Report on the CD34 cluster workshop, in Knapp W, Dorken B, Gilk W, Rieber E, Stein H, Schmidt R, von den Borne A (eds): Leukocyte Typing IV. Oxford, UK, Oxford University, 1989, p 818
8. + marrow cells engraft lethally irradiated baboons. Blood 77:1717, 1988
9. - marrow cells in patients with breast cancer or neuroblastoma. Blood 77:1717, 1991
10. Wagermaker G, van Gils F, Bart-Baumeister J, Weilenger J, Levinsky R: Sustained engraftment of allogenic CD34 positive hematopoietic stem cells in rhesus monkeys. Exp Hematol 18:708, 1990
11. Krause D, Ito T, Fackler M, Collector M, Sharkis S, May W: Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood 84:691, 1994
12. Baumhueter S, Singer MS, Henzel W, Hemmerich S, Renz M, Rosen SD, Lasky LA: Binding of L-selection to the vascular sialomucin CD34. Science 262:436, 1993
13. Baumhueter S, Dybdai N, Kyle C, Lasky L: Global vascular expression of murine CD34, a sialomucin-like endothelial ligand for L-selectin. Blood 84:2554, 1994
14. Sutherland D, Keating A: The CD34 antigen: Structure, biology, and potential clinical applications. J Hematother 1:115, 1992
15. Delia D, Lampugnani M, Resnati M, Dejana E, Aiello A, Fontanella E, Soligo D, Pierotti M, Greaves M: CD34 expression is regulated recriprocally with adhesion molecules in vascular endothelial cells in vitro. Blood 81:1001, 1993
16. Fackler MJ, Civin CI, May WS: Up-regulation of surface CD34 is associated with protein kinase C-mediated hyperphosphorylation of CD34. J Biol Chem 267:17540, 1992
17. Majdic O, Stockl J, Pickl WF, Bohuslav J, Strobl H, Scheinecker C, Stockinger H, Knapp W: Signaling and induction of enhanced cytoadhesiveness via the hematopoietic progenitor cell surface molecule CD34. Blood 83:1226, 1994
18. Fackler M, Krause D, Smith O, Civin C, May W: Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells. Blood 85:3040, 1995
19. Uchansak-Ziegler B, Petrasch S, Michel J, Ziegler A: Characterization of the CD34-specific monoclonal antibody TUK3. Tissue Antigens 33:230, 1989
20. Watt SM, Karhi K, Gatter K, Furley AJW, Katz FE, Healy LE, Atass LJ, Bradley NJ, Sutherland DR, Levinsky R, Greaves MF. Distribution and epitope analysis of the cell membrance glycoprotein (HPCA-1) associated with human hemopoietic progenitor cells. Leukemia 1:417, 1987
21. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495, 1975
22. Loken MR, Shah VO, Dattilio KL, Civin CI: Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood 70:1316, 1987
23. Civin CI, Banquerigo ML, Strauss LC, Loken MR: Antigenic analysis of hematopoiesis VI Flow cytometric characterization of My-10 positive progenitor cells in normal human bone marrow. Exp Hematol 15:10, 1987
24. Strauss L, Rowley S, La Russa S, Stuart R, Civin C: Antigenic analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells. Exp Hematol 14:878, 1986
25. Andrews RG, Singer JW, Bernstein ID: Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J Exp Med 169:1721, 1989
26. Bernstein I, Leary A, Andrews R, Ogawa M: Blast colony-forming cells and precursors of colony-forming cells detectable in long-term marrow culture express the same phenotype (CD33-CD34+). Exp Hematol 19:680, 1991
27. Leary AG, Ogawa M: Blast cell colony assay for umbilical cord blood and adult bone marrow progenitors. Blood 69:953, 1987
28. Berardi A, Wang A, Levine J, Lorez P, Scadden D: Functional isolation and characterization of human hematopoietic stem cells Science 267:104, 1995
29. Gore SD, Kastan MB, Civin CI: Normal human bone marrow precursors that express terminal deoxynucleotidyl transferase include T-cell precursors and possible lymphoid stem cells. Blood 77:1681, 1991
30. Lin G, Finger E, Gutierrez-Ramos J: Expression of CD34 in endothelial cells, hematopoietic progenitors, and nervous cells in fetal and adult mouse tissues. Eur J Immunol 25:1508, 1995
31. Anthony P, Ramani P: Endothelial markers in malignant vascular tumors of the liver: Superiority of QBEnd/10 over von Willebrand factor and ULex europaeus agglutinin 1. J Clin Pathol 161:267, 1991
32. Sankey E, More I, Phillon A: QBEnd/10: A new immunostain for the routine diagnosis of Kaposi's sarcoma. J Pathol 161:267, 1990
33. Silvestri F, Banavali S, Baccarani M, Preisler HD: The CD34 hemopoietic progenitor cell associated antigen: Biology and clinical applications. Haematologica 77:265, 1992
34. Civin C: Purification and expansion of human hematopoietic stem cells, in Schlossman S, Boumsell L, Gilks W, Harlan J, Kishimoto T, Morimoto C, Ritz J, Shaw S, Sivlerstein R, Springer T, Tedder T, Todd R (eds): Leukocyte Typing V: White Cell Differentiation Antigens. New York, NY, Oxford University Press, 1995, p 869
35. Greaves M, Titley I, Colman S, Buhring H-J, Campos L, Castoldi G, Garrdo F, Gaudnack G, Girard J-P, Ingles-Esteve J, Invernizzi R, Knapp W, Lansdorp P, Lanza F, Merle-Beral H, Parravicini C, Razak K, Ruiz-Cabello F, Springer T, van der Schoot C, Sutherland D: M10 CD34 cluster workshop section, in Schlossman S, Boumsell L, Gilks W, Harlan J, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder T, Todd R (eds): Leukocyte Typing V: White Cell Differentiation Antigens. New York, NY, Oxford University Press, 1995, p 840
36. Koeffler HP, Billing R, Lusis AJ, Sparkes R, Golde DW: An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). Blood 56:265, 1980
37. Sutherland D, Marsh J, Davidson J, Baker M, Keating A, Mellors A: Differential sensitivity of CD34 epitopes to cleavage by Pasteurella haemolytica glycoprotease: Implications for purification of CD34-positive progenitor cells. Exp Hematol 20:590, 1992
38. Strauss LC, Trischmann TM, Rowley SD, Wiley JM, Civin CI: Selection of normal human hematopoietic stem cells for bone marrow transplantation using immunomagnetic microspheres and CD34 antibody. Am J Pediatr Hematol Oncol 13:217, 1991
39. Krause D, Fackler M, Smith O, May W: Two forms of CD34 protein are expressed in human KMT2 and KG1a cells. Blood 82:427a, 1993 (abstr, suppl 1)
40. PharMingen, San Diego, CA, 1995, Technical Data Sheet (Catalog Number 09431D)
41. He X, Antao V, Basila Marx J, Davis B: Isolation and molecular characterization of the human CD34 gene. Blood 79:2296, 1992
42. Simmons DL, Satterthwaite AB, Tenen DG, Seed B. Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells. J Immunol 148:267, 1992
43. Satterthwaite A, Burn T, LeBeau M, Tenen D: Structure of the gene encoding CD34, a human hematopoietic stem cell antigen. Genomics 12:788, 1992
44. Molgaard H, Spurr N, Greaves M: The hematopoietic stem cell antigen, CD34, is encoded by a gene located on chromosome 1. Nucleic Acids Res 10:459, 1989
45. McSweeney P, Bolles L, deRevel T, Storb R, Nash R: Cloning of cDNA encoding canine CD34. Blood 84:271a, 1994 (abstr, suppl 1)
46. Molgaard H, Spurr N, Greaves M: The hematopoietic stem cell antigen, CD34, is encoded by a gene located on chromosome 1. Leukemia 3:773, 1989
47. Tenen DG, Satterthwaite AB, Borson R, Simmons D, L ER, Shows TB: Chromosome 1 localization of the gene for CD34, aa surface antigen of human stem cell. Cytogenet Cell Genet 53:55, 1989
48. Watson M, D'Eustachio P, Mock B, Steinberg A, Morse H, Oakley R, Howard T, Tockelle J, Seldin M: A linkage map of mouse chromosome 1 using an interspecific cross segregating for the gld autoimmunity mutation. Mamm Genome 2:158, 1992
49. Bruns G, Sherman S: Report of the committee on the genetic constitution of chromosome 1. Cytogenet Cell Genet 51:67, 1988
50. Atkin N: Chromosome 1 aberrations in cancer. Cancer Genet Cytogenet 21:279, 1986
51. Nakamura Y, Komano H, Nakauchi H: Two alternative forms of cDNA encoding CD34. Exp Hematol 21:236, 1993
52. Suda J, Sudo T, Ito M, Ohno N, Yamaguchi Y, Suda T: Two types of murine CD34 mRNA generated by alternative splicing. Blood 79:2288, 1992
53. Pallant A, Eskenazi A, Mattei M: Characterization of cDNAs encoding humna leukosialin and localization of the leukosialin gene to chromosome 16. Proc Natl Acad Sci USA 86:1328, 1989
54. Killeen N, Barclay AN, Willis AC, Williams AF: The sequence of rat leukosialin (W3/13 antigen) reveals a molecule with O-linked glycosylation of one third of its extracellular amino acids. EMBO J 6:4029, 1987
55. Axelsson B, Hammarstrom S, Finne J, Perlmann P: The large sialoglycoprotein of human lymphocytes. II. Biochemical features. Eur J Immunol 15:427, 1985
56. Axelsson B, Perlmann P: Persistent superphosphorylation of leukosialin (CD43) in activated T cells and in tumour cell lines. Scand J Immunol 30:539, 1989
57. Fackler MJ, Civin CI, Sutherland DR, Baker MA, May WS: Activated protein kinase C directly phosphorylates the CD34 antigen on hematopoietic cells. J Biol Chem 265:11056, 1990
58. Sutherland DR, Fackler MJ, May WS, Matthews KE, Baker MA: Activated protein kinase C directly phosphorylates the CD34 antigen in acute lymphoblastic leukemia cells. Leuk Lymphoma 8:337, 1992
59. Mustelin T, Coggeshall L, Altman A: Rapid activation of the T-cell tyrosine protein kinase pp56lck by the CD45 phosphotyrosine phosphatase. Proc Natl Acad Sci USA 86:6302, 1989
60. Bevilacqua M, Stengelin S, Gimbrone M, Seed B: Endothelial leucocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243:1160, 1989
61. Lublin M, Liszewski M, Post T: Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family. J Exp Med 168:181, 1988
62. Yamada K: Adhesive recognition sequences. J Biol Chem 266:12809, 1991
63. Prater C, Plotkin J, Jaye D, Frazier W: The properidin-like type 1 repeats of thombospondin contain a cell attachment site. J Cell Biol 112:1031, 1991
64. Rich K, George F, Law J, Martin W: Cell adhesive motif in region 11 of malarial circumsporozoite protein. Science 249:1574, 1990
65. Liesi P, Narvanen A, Soos J: Identification of a neurite outgrowth-promoting domain of laminin using synthetic peptides. FEBS Lett 244:141, 1989
66. Jentoft N: Why are protein O-glycosylated? Trends Biochem Sci 15:291, 1990
67. Yamaguchi Y, Suda T: Functional characterization of the murine CD34 promoter Blood 84:15a, 1994 (abstr, suppl 1)
68. Morris J, Hromas R: Characterization of the DNA-binding properties of the myeloid zinc finger protein MZF1: Two independent DNA-binding domain recognize two DNA consensus sequences with a common G-rich core. Mol Cell Biol 14:1786, 1994
69. Gonda T, Metcalf D: Expression of myb, myc, and fos protooncogenes during the differentiation of the murine myeloid leukemia. Nature 310:249, 1984
70. Cole M. The myc oncogene: its role in transformation and differentiation. Annu Rev Genet 20:361, 1986
71. Gewirtz A, Calabretta B: A c-myb antisense oligonucleotide inhibits normal human hematopoiesis in vitro. Science 242:1303, 1988
72. Mucenski M, McLain K, Kier A, Swerdlou S, Schieiner C, Miller T, Pietryga D, Scott W, Potter S: A functional c-myb gene is required for normal mouse fetal hepatic hematopoiesis. Cell 65.677, 1991
73. Melotti P, Ku D-H, Calabretta B: Regulation of the expression of the hematopoietic stem cell antigen CD34. Role of c-myb. J Exp Med 179:1023, 1994
74. Kastan MB, Stone KD, Civin CI: Nuclear oncoprotein expression as a function of lineage, differentiation stage and proliferative status of normal human hematopoietic cells. Blood 74:1517, 1989
75. Melotti P, Calabretta B: Ets-2 and c-myb act independently in regulating expression of the hematopoietic stem cell antigen CD34. J Biol Chem 269:25303, 1994
76. Morris J, Rausher F, Davis B, Scadden D, Hromas R: The myeloid zinc finger gene MZF-1 represses the CD34 promoter. Blood 84:1450a, 1994 (abstr, suppl 1)
77. Burn T, Satterwaithe A, Tenen D: The human CD34 hematopoietic stem cell antigen promoter and a 3′ enhancer direct hematopoietic expression in tissue culture. Blood 80:3051, 1992
78. He X, Cockeril P, Cen D, Davis B: Transcriptional regulation and chromatin structure of the human CD34 gene promoter region. Blood 83:1822, 1994
79. May G, Enver T: Targeting gene expression to hematopoietic stem cells: A chromatin-dependent upstream element mediates cell type-specific expression of the stem cell antigen CD34. EMBO J 14:564, 1995
80. Satterthwaite A, Borson R, Tenen D: Regulation of the gene for CD34, a human hematopoietic stem cell antigen, in KG-1 cells. Blood 75:2299, 1990
81. Caput D, Bentler B, Hartag K, Thayer R, Brown-Shimer S, Cerami A: Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA 83:1670, 1986
82. Shaw G, Kamen R: A conserved Au sequence from the 3′-untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659, 1986
83. Schuler G, Cole M: GM-CSF and oncogene mRNA stabilities are independently regulated in trans in a mouse monocytic tumor. Cell 55:1115, 1988
84. Malter J: Identification of an AUUUA-specific messenger RNA binding protein. Science 246:664, 1989
85. Kozak M: An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol 115:887, 1991
86. Sullivan J, Connor J, Shearer B, Tiffany C, Burch R: 2.6-Diamino-N-([1-(1-Oxotridecyl)-2-piperidinyl]methyl) Hexan-amide (NPC 15437): A novel, selective inhibitor of protein kinase C interacting at the regulatory domain. FEBS Lett 285:120, 1991
87. Fackler M, Nolta J, Kohn D, Civin C, May W: Physiological activators of PKC can induce CD34 hyperphosphorylation. Blood 80:1176a, 1992 (abstr, suppl 1)
88. Springer T: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76:301, 1994
89. May G, Healy L, Gale K, Greaves M: Functional analysis of the stem cell antigen CD34 in transgenic mice. Blood 84:871, 1994
90. Borowitz MJ, Gockerman JP, Moore JO, Civin CI, Pagew SO, Robertson J, Bigner SH: Clinicopathologic and Cytogenetic Features of Cd34 (My10)-positive acute nonlymphocytic leukemia. Am J Clin Pathol 91:265, 1989
91. Soligo D, Delia D, Oriani A, Cattoretti G, Orazi A, Bertolli V, Quiric N, Deliliers G: Identification of the CD34+ cells in normal and pathologic bone marrow biopsies by QBEND 10 monoclonal antibody. Leukemia 5:1026, 1991
92. Vaughan WP, Civin CI, Weisenburger DD, Karp JE, Graham ML, Sanger WG, Grierson HL, Joshi SS, Burke PJ: Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY10). Leukemia 2:661, 1988
93. Geller RB, Zahurak M, Hurwitz CA, Burke PJ, Karp JE, Piantadosi S, Civin CI: Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: The significance of the stem-cell glycoptotein CD34 (My10) [see comments]. Br J Haematol 76:340, 1990
94. Katz F, Watt S, Martin H: Coordinate expression of BI.3C5 and HLA-DR antigens on haemopoietic progenitors from chronic myeloid leukaemia. Leuk Res 10:961, 1986
95. Hurwitz C, Raimondi S, Head D, Krance R, Mirro J, Kalwinsky D, Ayers G, Behm F: Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children. Blood 80:3182, 1992
96. Adriaansen H, teBoekhorst P, Hagemeijer A, van der Schoot C, Delvwel H, van Donger J: Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and in v(16)(p13q22) exhibits a specific immunophenotype with CD2 expression. Blood 81:3043, 1993
97. Guyotat D, Campos L, Thomas Z, Vila L, Shi Z, Charrin C, Gentilhomme O, Fiere D: Myelodysplastic syndromes: A study of surface markers and in vitro growth patterns. Am J Hematol 34:26, 1990
98. Lee EJ, Yang J, Leavitt RD, Testa JR, Civin CI, Forrest A, Schiffer CA: The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia. Leukemia 6:1203, 1992
99. Campos L, Guyotat D, Archimbaud E, Calmard-Oriol P, Tsuruo T, Troncy J, Treille D, Fiere D: Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood 79:473, 1992
100. Chaudhary PM, Roninson IB: Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66:85, 1991
101. Kastan MB, Schaffer E, Russo JE, Colvin OM, Civin CI, Hilton J: Direct demonstration of elevated aldehydehydrogenase in human hematopoietic progenitor cells. Blood 75:1947, 1990
102. Pui CH, Behm FG, Crist WM: Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 82:343, 1993
103. Hurwitz CA, Gore SD, Stone KD, Civin CI: Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells. Leukemia 6:233, 1992
104. Hurwitz CA, Loken MR, Graham ML, Karp JE, Borowitz MJ, Pullen DJ, Civin CI: Asynchronous antigen expression in B lineage acute lymphoblastic leukemia. Blood 72:299, 1988
105. Borowitz MJ, Shuster JJ, Civin CI, Carroll AJ, Look AT, Behm FG, Land VJ, Pullen DJ, Crist WM: Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: A Pediatric Oncology Group study. J Clin Oncol 8:1389, 1990
106. Trischmann TM, Schepers KG, Civin CI. Measurement of CD34+ cells in bone marrow by flow cytometry. J Hematother 2.305, 1993
107. Loken M, Civin C: Laboratory Assessment of Lympho-hematopoietic Progenitor and Stem Cells, in Smith D, Sacher R (eds): Peripheral Blood Stem Cells. Bethesda, MD, American Association of Blood Banks, 1993, p 19
108. Civin C: Purified progenitor/stem cells: Background, feasibility, and prospects for clinical transplantation. Int J Cell Clon 10:16, 1992
109. Siena S, Bregni M, Gianni M: Estimation of peripheral blood CD34+ cells for autologous transplantation in cancer patients. Exp Hematol 21:203, 1993
110. Sutherland D, Keating A, Nayar R, Anania S, Stewart A: Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol 22:1003, 1994
111. Pettengell R, Testa NG, Swindell R, Crowther D, Dexter TM: Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma [see comments]. Blood 82:2239, 1993
112. Passos-Coelho J, Ross A, Moss T, Davis J, Huelskamp A, Noga S, Davidson N, Kennedy M: Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte-macrophage colony-stimulating factor. Blood 85:1138, 1995
113. + hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: Enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 74:1905, 1989
114. Haas R, Mohle R, Fruhauf S, Goldschmidt H, Witt B, Flentje M, Wannenmacher M, Hunstein W: Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83:3787, 1994
115. Shpall FJ, Jones RB, Bearman SI, Franklin WA, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer SM, Purdy M, Myers SE, Hami L, Taffs S, Heimfeld S, Hallagan J, Berenson RJ: Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 12:28, 1994
116. Bender J, To LB, Williams S, Schqartzberg L: Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1:329, 1992
117. Nickolof B: The human progenitor cell antigen (CD34) is localized on endotherlial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma. Arch Dermatol 127:523, 1991
118. Rill DR, Santana VM, Roberts WM, Nilson T, Bowman LC, Krance RA, Heslop HE, Moen RC, Ihle JN, Brenner MK: Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84.380, 1994
119. Civin CI, Trischmann T, Davis J, Noga S, Cohen K, Duffy B, Wiley J, Law P, Hardwick A, Oldham F, Gee A: Highly purified CD34+ Cells Reconstitute hematopoiesis. Proc Am Soc Clin Oncol 14:437, 1995
120. Schmitz N, Dreger P, Suttorp M: Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 85:1666, 1995
121. Martin P: Marrow manipulation: T cell depletion protocols, in Ferrara J, Deeg J, Burakoff S (eds): Graft vs. Host Disease (ed 2). New York, NY, Dekker, 1995
122. Champlin R, Giralt S, Przepiorka D: Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: Engraftment, graft-versus-host disease, and graft-versus-leukemia. Prog Clin Biol Res 377:385, 1992
123. Goldman J: Peripheral blood stem cells for allografting. Blood 85:1413, 1995
124. Korbling M, Prsepiorka D, Huh Y, Engel H, Van Besien K, Giralt S, Andersson B, Kleine H, Seong D, Deisseroth A, Andreeth M, Champlin R: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 85:1659, 1995
125. Noga S, Hess A: Lymphocyte depletion in bone marrow transplantation. Will moduation of graft-versus-host disease prove to be superior to prevention? Semin Oncol 20:28, 1993
126. Kessinger A: Circulating stem cells - Waxing hematopoietic. N Engl J Med 333:315, 1995
127. Deisseroth A, Zu S, Claxton D: Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow transplantation in CML. Blood 83:3068, 1994
128. + cells into the myeloid lineage. Blood 80:1405, 1992
129. Muench MO, Firpo MT, Moore MA: Bone marrow transplantation with interleukin-1 plus kit-ligand ex vivo expanded bone marrow accelerates hematopoietic reconstitution in mice without the loss of stem cell lineage and proliferative potential. Blood 81:3463, 1993
130. Brugger W, Heimbeld S, Berenson R, Mertelsmann R, Kanz L: Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 333:283, 1995
131. McClanahan T, Dalrymple S, Barkett M, Lee F: Hematopoietic growth factor receptor genes as markers of lineage commitment during in vitro development of hematopoietic cells. Blood 81:2903, 1993
132. DiGiusto D, Chen S, Combs J, Webb S, Namikawa R, Tsukamoto A, Chen B, Galy A: Human fetal bone marrow early progenitors for T, B and myeloid cells are found exclusively in the population expressing high levels of CD34. Blood 84:421, 1994
133. Tamura S, Sugawara M, Tanaka H, Tezuka E, Nihira S-I, Miyamoto C, Suda T: A new hematopoietic cell line, KMT-2, having human interleukin-3 receptors. Blood 76:501, 1990
134. Cardoso A, Li M, Batard P: Release from quiescence of CD34+ CD38- human umbilical cord blood cells reveals their potentiality to engraft adults. Proc Natl Acad Sci USA 90:8707, 1993
135. +-+ human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential. Blood 81:41, 1993
136. Broxmeyer HE, Hangoc G, Cooper S, Ribeiro RC, Graves V, Yoder M, Wagner J, Vadhan-Raj S, Benninger L, Rubinstein P, Broun RE. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA 89:4109, 1992
137. Gluckman E, Broxmeyer HE, Auerbach AD, Friedman HS, Douglas GW, Devergie A, Experou H, Thierry D, Socie G, Lehn P, Cooper S, English D, Kurtzberg J, Bard J, Boyse EA: Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321:1174, 1989
138. Hows JM, Bradley BA, Marsh JCW, Luft T, Coutinho L, Testa NG, Dexter TM: Growth of human umbilical-cord blood in long-term haemopoietic cultures. Lancet 340:73, 1992
139. Ramani P, Bradley N, Fletcher C: QBEnd/10, a new monoclonal antibody to endothelium: Assessment of its diagnostic utility in paraffin section. Histopathology 17:237, 1990
140. - hematopoietic stem cells. Blood 83:1515, 1994
141. + cells. Blood 80:429, 1992